Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Biotricity Inc. (OTC: BTCY).

Full DD Report for BTCY

You must become a subscriber to view this report.


Recent News from (OTC: BTCY)

San Antonio Endovascular & Heart Institute First to Deploy Biotricity's New Bioflux Remote Monitoring Device
REDWOOD CITY, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced that the San Antonio Endovascular &...
Source: GlobeNewswire
Date: April, 23 2018 08:00
Biotricity Reviews Fiscal Year 2017 Milestones and Outlines 2018 Goals
REDWOOD CITY, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today provided a progress update for the end of the 2017 f...
Source: GlobeNewswire
Date: April, 03 2018 08:00
Biotricity Appoints Casey Shattuck as New VP of Sales to Spearhead Bioflux Launch
REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced the company has appointed Mr. Casey Shattu...
Source: GlobeNewswire
Date: March, 13 2018 08:00
Biotricity Announces Commercial Rollout of Proprietary Bioflux Device
REDWOOD CITY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced the commercial availability of Bioflux , a...
Source: GlobeNewswire
Date: March, 05 2018 08:00
Imminent Healthcare Device Launch Could Send Little BTCY Soaring
- Wearable healthcare technology hasn't translated into gains for these companies and their stocks yet, despite hype around the potential for health tracking - Medical-grade products are producing massively for medical device companies, meanwhile, with medical device ETF climbing 300%...
Source: Livemoney
Date: February, 27 2018 08:08
Biotricity Update for Shareholders
REDWOOD CITY, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY ), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has witnessed a phenomenal fourth quarter; the Company achiev...
Source: GlobeNewswire
Date: February, 12 2018 08:00
Medical-Grade Wearable Provider Biotricity Aims to Increase Patient Adherence
REDWOOD CITY, Calif., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is poised to change cardiac healthcare into a preventive ...
Source: GlobeNewswire
Date: January, 26 2018 08:00
Biotricity Announces the Addition of Artificial Intelligence to its Remote Patient Monitoring Platform
REDWOOD CITY, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced it has commenced extending the capabilities of i...
Source: GlobeNewswire
Date: January, 16 2018 08:00
Biotricity Expands its R&D Effort to Capitalize on Artificial Intelligence
REDWOOD CITY, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is currently expanding its research and development to incl...
Source: GlobeNewswire
Date: January, 08 2018 08:00
Biotricity Expands its R&D Effort to Capitalize on Artificial Intelligence
Biotricity Expands its R&D Effort to Capitalize on Artificial Intelligence
Source: OTC Markets
Date: January, 08 2018 00:00

 


About Biotricity Inc. (OTC: BTCY)

Logo for Biotricity Inc. (OTC: BTCY)

Biotricity is a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post diagnostic solutions for chronic conditions and lifestyle improvement. To learn more, visit www.biotricity.com.

 

Contact Information

 

 

Current Management

  • Waqaas AlSiddiq / President, CEO
  • Tom Nelson / Advisory Director
  • John Rother / Advisory Director
  • Bernard Rice / Advisory Director
  • Danny Sands / Advisory Director
  • Nayyar Razvi / Advisory Director
  • David Liepert / Advisory Director
  • Waqaas AlSiddiq / Chairman
  • Norman Betts / Independent Director
  • Dave Rosa / Independent Director

Current Share Structure

  • Market Cap: $89,584,337 - 03/09/2018
  • Authorized: 125,000,000 - 02/05/2016
  • Issue and Outstanding: 23,268,659 - 02/12/2018
  • Float: 4,500,000 - 08/09/2016

 


Recent Filings from (OTC: BTCY)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 16 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: March, 13 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: March, 09 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: March, 09 2018
Amendment to general form for registration of securities under the Securities Act of 1933
Filing Type: S-1/AFiling Source: edgar
Filing Date: March, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 05 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2018
General form for registration of securities under the Securities Act of 1933
Filing Type: S-1Filing Source: edgar
Filing Date: February, 09 2018

 

 


Daily Technical Chart for (OTC: BTCY)

Daily Technical Chart for (OTC: BTCY)


Stay tuned for daily updates and more on (OTC: BTCY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BTCY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BTCY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of BTCY and does not buy, sell, or trade any shares of BTCY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/